Возраст домена | 24 года |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | 10 |
Страниц в Google | 3010 |
Страниц в Яндексе | 589 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 1169788 |
Alexa Country | 58313 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
NEWS | Treatment Action Group
n/a
n/a
UTF-8
135.86 КБ
2 500
57 263 симв.
48 063 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
aids2014.org | 54 | 6 |
20 | 3437845 | Нет данных | |
aidsresearch.org | 28 | 5 |
0 | 1645361 | Нет данных | |
hivresearch.org | 21 | 5 |
10 | 2223249 | 811068 | |
imstilljosh.com | 19 | 3 |
0 | 4149519 | Нет данных | |
pcr-proven-hiv-cure.com | 16 | 3 |
10 | Нет данных | Нет данных | |
angiochem.com | 16 | 4 |
10 | 8252236 | Нет данных | |
hanstenandhorn.com | 15 | 3 |
0 | 3488950 | Нет данных | |
solvobiotech.com | 15 | 5 |
0 | 2263076 | 1092481 | |
hepccenter.org | 13 | 5 |
0 | 17485697 | Нет данных | |
fluorosome.com | 13 | 3 |
0 | Нет данных | Нет данных | |
nih.gov | 7 | 8 |
0 | 113 | 65 | |
cdc.gov | 5 | 9 |
0 | 1483 | 400 | |
who.int | 4 | 8 |
0 | 1571 | 2333 | |
nhs.uk | 3 | 7 |
0 | Нет данных | Нет данных | |
webmd.com | 3 | 7 |
0 | 552 | 197 | |
stoptb.org | 3 | 7 |
50 | 369049 | 50075 | |
medicinenet.com | 3 | 7 |
0 | 4097 | 1342 | |
case.edu | 2 | 7 |
0 | 11003 | 2723 | |
amfar.org | 2 | 6 |
30 | 451729 | 160671 | |
aids.gov | 2 | 8 |
0 | 9571869 | Нет данных | |
Еще 30 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 23 Декабря 2016 ) | |
Количество ссылок на сайт | 1610 |
Количество доменов, которые ссылаются на сайт | 303 |
Количество найденных анкоров | 300 |
Исходящие (внешние) ссылки домена | 7918 |
Количество доменов, на которые ссылается сайт | 634 |
Количество исходящих анкоров | 1142 |
Внешние ссылки главной страницы ( 10 ) | |
treatmentactiongroup.salsalabs.org/2019donate | <img> |
treatmentactiongroup.salsalabs.org/emailsignup | <img> |
charitynavigator.org/index.cfm?bay=search.summary&orgid=9373 | <img> |
guidestar.org/profile/13-3624785 | <img> |
ncsddc.org/ | NCSD |
clinicaltrials.gov/ | ClinicalTrials.gov |
healthgap.org/what_is_missing_from_the_united_nations_politi... | What's Missing from the UN Political Declaration on Tuberculosis? |
facebook.com/pages/Treatment-Action-Group-TAG/129611149140 | |
twitter.com/#!/TAGTeam_Tweets | |
drupal.org | Drupal |
Внутренние ссылки главной страницы ( 181 ) | |
/ | HOME |
/hiv | HIV |
treatmentactiongroup.org/cure | Cure |
/hcv | HCV |
treatmentactiongroup.org/hcv/factsheets | New HCV Fact Sheets |
treatmentactiongroup.org/content/updated-training-manual-hcv... | Updated Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV |
/tb | TB |
treatmentactiongroup.org/tb/combatting-rising-tb-new-york | Combatting Rising TB in New York |
treatmentactiongroup.org/basic-science | Blog |
treatmentactiongroup.org/hiv/hiv-aging-resources | HIV/Aging |
treatmentactiongroup.org/basic-science/publications/clinical... | Immunologic Nonresponders |
treatmentactiongroup.org/basic-science/publications | Publications |
treatmentactiongroup.org/basic-science/vaccines | Vaccines |
/policy | POLICY |
treatmentactiongroup.org/pipeline-report | 2019 Pipeline Report |
treatmentactiongroup.org/tagline | Fall, 2018 TAGline: Bringing Down the House on Intellectual Property and Access |
treatmentactiongroup.org/ete | Ending the HIV/AIDS Epidemic |
treatmentactiongroup.org/riaa/2019 | <img> |
/limited-art-editions | <img> |
treatmentactiongroup.org/content/2018-annual-report-appeal | <img> |
treatmentactiongroup.org/give | <img> |
/mission | MISSION |
/history | HISTORY |
/publications | PUBLICATIONS |
/press | PRESS |
/board | BOARD |
/staff | STAFF |
/support | SUPPORT |
/content/contact | CONTACT |
/annual-reports | ANNUAL REPORTS |
treatmentactiongroup.org/cure/trials | Research Toward a Cure |
treatmentactiongroup.org/content/tag-welcomes-hhs-lawsuit-ag... | TAG Welcomes HHS Lawsuit Against Gilead; Urges Dramatic Scale-Up of Low-Cost PrEP |
treatmentactiongroup.org/content/landscape-analysis-hiv-cure... | A Landscape Analysis of HIV Cure-Related Clinical Trials in 2018 |
treatmentactiongroup.org/content/acclaimed-american-artist-g... | Acclaimed American Artist Glenn Ligon Creates Black Rage (back cover) as a Limited Art Edition for Treatment Action Group’s 2019... |
treatmentactiongroup.org/content/tag-comment-response-propos... | TAG Comment in Response to Proposed Rulemaking: Visas: Ineligibility Based on Public Charge Grounds |
treatmentactiongroup.org/content/activist-guide-hepatitis-c-... | Activist Guide to Hepatitis C Virus Diagnostics |
treatmentactiongroup.org/content/public-investments-tb-medic... | Public Investments in TB Medicine Bedaquiline Far Exceed Those of Developer Johnson & Johnson |
treatmentactiongroup.org/content/protestors-demand-cepheid-h... | Protestors Demand Cepheid Halve the Price of GeneXpert TB Tests to US$5 |
treatmentactiongroup.org/content/lower-price-rifapentine-jus... | A Lower Price for Rifapentine Is Just a Start—Communities Need More Than Discounts to Access TB Preventive Therapy! |
treatmentactiongroup.org/content/eight-hivaids-research-poli... | Eight HIV/AIDS Research, Policy, and Advocacy Organizations File an Amici Curiae Brief in Staley v. Gilead – Background and Next... |
treatmentactiongroup.org/content/job-opportunity-development... | Job Opportunity: Development Manager |
treatmentactiongroup.org/content/ensuring-community-leadersh... | Ensuring Community Leadership as Part of the Federal Ending the HIV Epidemic (EHE): A Plan for America |
treatmentactiongroup.org/content/statement-corrective-action... | Statement: Truly Corrective Actions on Drug Pricing Will Bring Life-Saving Benefit to Consumers in the U.S. and Globally |
treatmentactiongroup.org/content/restricted-fda-approval-des... | Following Restricted FDA Approval of Descovy As PrEP, TAG Calls on Gilead to Immediately Partner with Community for Research on ... |
treatmentactiongroup.org/content/webinar-advocates-debrief-s... | Advocates’ Debrief on the Science of Daily F/TAF vs. TDF/FTC as PrEP |
treatmentactiongroup.org/content/statement-anea-response-gua... | ANEA Response to Guardian Article on Gov. Rick Scott’s Rejection of $70 Million in Federal Funding to Fight Florida’s HIV/AIDS C... |
treatmentactiongroup.org/content/statement-us-fda-report-hig... | Statement on U.S. FDA Report Highlighting Gaps in Pediatric Research |
treatmentactiongroup.org/content/ensuring-treatment-children... | Ensuring Treatment for Children with Orphan Diseases: Ending Exemptions from the Pediatric Research Equity Act (PREA) |
treatmentactiongroup.org/content/statement-tag-joins-collect... | Statement: Treatment Action Group Joins Collective Call Denouncing the Trump Administration’s Dangerous Finalized Anti-Immigrant... |
treatmentactiongroup.org/content/statement-treatment-action-... | TAG Statement on U.S. FDA Approval of Pretomanid |
treatmentactiongroup.org/content/tag-public-comment-proposed... | TAG Public Comment on Proposed Rule to Remove Section 1557 |
treatmentactiongroup.org/content/tag-comments-delivered-fda-... | TAG Comments Delivered at FDA Public Meeting on LPAD |
treatmentactiongroup.org/content/letter-regarding-appointmen... | Letter Regarding the Appointment of a New Executive Director at UNAIDS |
treatmentactiongroup.org/content/tag-prep4all-joint-comment-... | TAG, PrEP4All Joint Comment on DESCOVY for FDA Hearing, 8-7-19 |
treatmentactiongroup.org/content/statement-treatment-action-... | Statement: Treatment Action Group Applauds U.S. Preventive Services Task Force “A” Ratings for Pre-Exposure Prophylaxis and HIV ... |
treatmentactiongroup.org/content/letter-tag-and-55-allied-or... | TAG and 55 Allied Organizations Denounce the Trump Administration's Ban on Fetal Tissue Research |
treatmentactiongroup.org/content/written-senate-testimony-fy... | Written Senate Testimony for FY 2020 for the CDC's Domestic TB Elimination Program and Division of Global HIV and TB |
treatmentactiongroup.org/content/written-senate-testimony-fy... | Written Senate Testimony for FY 2020 for the USAID Global TB Program |
treatmentactiongroup.org/content/written-senate-testimony-fy... | Written Senate Testimony for FY 2020 for HIV Research Funding at NIAID and OAR |
treatmentactiongroup.org/content/tag-testimony-fda-new-drug-... | TAG Testimony to the FDA on New Drug Application for Pretomanid Tablets |
treatmentactiongroup.org/content/advocates-raise-serious-con... | Advocates Raise Serious Concerns About Errors in the WHO Guidelines for the Treatment of Drug-Resistant TB |
treatmentactiongroup.org/content/webinar-high-cost-prep-upda... | The High Cost of PrEP: Updates on Community and Health Department Efforts to Get Affordable TDF/FTC (Truvada) to Those Who Need ... |
treatmentactiongroup.org/content/tag-remembers-andy-velez-19... | TAG Remembers Andy Velez (1939—2019) |
treatmentactiongroup.org/content/submitted-testimony-congres... | TAG Submitted Testimony to the House Committee on Oversight and Reform Hearing on “HIV Prevention Drug: Billions in Corporate Pr... |
treatmentactiongroup.org/content/tag-comments-response-propo... | TAG Comments in Response to Proposed Rulemaking on Basic Health Program |
treatmentactiongroup.org/content/letter-addressing-conflict-... | Letter Addressing Conflict of Interest Created by J&J Donations of Bedaquiline in India |
treatmentactiongroup.org/content/letter-addressing-global-he... | Letter Addressing the Global Health and Human Rights Crisis Among People Who Use Drugs |
treatmentactiongroup.org/content/activists-guide-rifapentine... | An Activist’s Guide to Rifapentine for the Treatment of TB Infection |
treatmentactiongroup.org/content/letter-fda-regarding-applic... | Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV |
treatmentactiongroup.org/content/mark-harrington-senate-brie... | Mark Harrington Senate Briefing Transcript, 3-28-19 |
treatmentactiongroup.org/content/tb-lam-testing-briefs-2019 | TB LAM Testing Briefs |
treatmentactiongroup.org/content/written-testimony-fy-2020-c... | Written Testimony for FY 2020 for the CDC's Domestic TB Elimination Program |
treatmentactiongroup.org/content/written-testimony-fy-2020-a... | Written Testimony for FY 2020 Appropriations for NIH HIV/AIDS Research Agenda |
treatmentactiongroup.org/content/advocates-must-press-cdc-en... | Advocates Must Press the CDC to Enforce its PrEP Patents in Order to End HIV as an Epidemic |
treatmentactiongroup.org/content/join-tag-march-31st-los-ang... | Join TAG on March 31st in Los Angeles to Honor Liza Minnelli |
treatmentactiongroup.org/content/letter-asking-include-tb-pr... | Letter Asking to Include TB in President’s Plan to End HIV Epidemic |
treatmentactiongroup.org/content/gene-editing-hiv-research | Gene Editing in HIV Research |
treatmentactiongroup.org/content/letter-urging-support-measu... | Letter Urging Support at UN Commission on Narcotic Drugs for Measures to Prevent & Treat Hep C Among People Who Use Drugs |
treatmentactiongroup.org/content/pipeline-gonorrhea-chlamydi... | Pipeline for Gonorrhea, Chlamydia, and Syphilis |
treatmentactiongroup.org/content/tag-testimony-house-sfops-a... | TAG Testimony to House SFOPS Appropriations Subcommittee |
treatmentactiongroup.org/content/anea-statement-presidents-f... | ANEA Statement on the President’s Fiscal Year 2020 Budget Proposal |
treatmentactiongroup.org/content/treatment-action-group-stat... | Treatment Action Group Statement on the President’s Fiscal Year 2020 Budget Proposal |
treatmentactiongroup.org/content/statement-treatment-action-... | Statement from Treatment Action Group on FDA Priority Review of TB Alliance’s New Anti-TB Drug Pretomanid |
treatmentactiongroup.org/content/letters-support-protecting-... | Letters of Support – Protecting Equitable Health for all New Yorkers, Including Undocumented Adults and Those with Temporary Pro... |
treatmentactiongroup.org/content/treatment-action-group-stat... | Treatment Action Group Statement on New HIV Remission Case from Stem Cell Transplantation Study |
treatmentactiongroup.org/content/pre-croi-community-hiv-cure... | Pre-CROI Community HIV Cure Research Workshop 2019 |
treatmentactiongroup.org/content/mdr-tb-treatment-guideline-... | MDR-TB Treatment Guideline Communication from NYC DOHMH |
treatmentactiongroup.org/content/eatan-hivaids-hepatitis-c-c... | EATAN HIV/AIDS & Hepatitis C Community Summit Report |
treatmentactiongroup.org/content/closing-gap-tuberculosis-re... | Closing the Gap in Tuberculosis Research and Development Funding Briefs |
treatmentactiongroup.org/content/tag-and-allies-rally-afford... | TAG and Allies Rally for Affordable HIV Prevention Medication |
treatmentactiongroup.org/content/statement-president-trump%E... | Statement on President Trump’s State of the Union Remarks on Ending the U.S. HIV Epidemic by 2030 from the Act Now: End AIDS Coa... |
treatmentactiongroup.org/content/verbal-comment-presidential... | Verbal Comment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria |
treatmentactiongroup.org/content/public-comment-nida-strateg... | Public Comment on NIDA Strategic Plan for Research at the Intersection of HIV/AIDS and Substance Use, Misuse, and Addiction |
treatmentactiongroup.org/content/webinar-good-cops-or-bad-co... | WEBINAR: Good COPs or Bad COPs 2.0: Advocacy to Ensure the Prioritization of TB in 2019 PEPFAR Country Operational Plans |
treatmentactiongroup.org/content/public-comment-identifying-... | Public Comment to the FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions for TB Drugs in the U.... |
treatmentactiongroup.org/content/fetal-tissue-research-lette... | TAG and 75 Other Orgs Send Fetal Tissue Research Letter To Alex Azar |
treatmentactiongroup.org/content/public-comment-uspstf-draft... | Public Comment on USPSTF Draft Recommendations for PrEP and HIV Screening |
treatmentactiongroup.org/content/webinar-cutting-costs-inclu... | WEBINAR: Cutting Costs by Including Cheaper ARVs on the New York State Medicaid Preferred Drug List for treatment, PEP, and pote... |
treatmentactiongroup.org/content/comment-response-proposed-r... | Comment in Response to Proposed Rulemaking: Regulation to Require Drug Pricing Transparency |
treatmentactiongroup.org/content/2018-tag-update | December 2018 TAG Update |
treatmentactiongroup.org/content/comment-response-proposed-r... | Comment in Response to Proposed Rulemaking: Inadmissibility on Public Charge Grounds |
treatmentactiongroup.org/content/sofosbuvirs-5th-birthday-ca... | Campaign for Sofosbuvir's 5th Birthday |
treatmentactiongroup.org/content/hepatitis-cure-sofosbuvir-t... | Hepatitis Cure, Sofosbuvir, Turns 5 Years Old: The Vast Majority of People Still Have Not Been Treated |
treatmentactiongroup.org/content/tbrd2018 | Tuberculosis Research Funding Trends 2005 – 2017 |
treatmentactiongroup.org/content/treatment-action-group-stat... | Treatment Action Group Statement on the Reported Birth of Twins with Edited CCR5 Genes |
treatmentactiongroup.org/content/tag-comment-penalties-relat... | TAG Comment on Penalties Relating to the ClinicalTrials.gov Data Bank |
treatmentactiongroup.org/content/community-recommendations-c... | Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions in Adults |
treatmentactiongroup.org/content/open-appeal-urgent-need-add... | OPEN APPEAL: URGENT NEED TO ADDRESS THE GLOBAL FUND PROCUREMENT CLIFF FOR TB |
treatmentactiongroup.org/content/rapid-shift-global-national... | Rapid Shift From Global To National Purchase of TB Drugs Increases Risk of Stockouts and Use of Drugs of Unknown Quality |
treatmentactiongroup.org/content/activists-urge-national-tb-... | Activists Urge National TB Programs and Treatment Providers To Discontinue Use of Harmful Injectable Agents in TB Treatment |
treatmentactiongroup.org/content/activists-call-countries-an... | Activists Call on Countries and Donors To Immediately Scale Up Use of Life-Saving TB LAM Test |
treatmentactiongroup.org/content/national-tb-checklist | National TB Checklist |
treatmentactiongroup.org/content/reality-check-price-of-beda... | Reality Check: The Price of Bedaquiline |
treatmentactiongroup.org/content/right-science-october-2018 | Right to Science Submission, October 2018 |
treatmentactiongroup.org/content/tb-human-rights-and-univers... | TB, Human Rights, and Universal Periodic Review |
treatmentactiongroup.org/tb/publications/2013/activist-guide... | An Activists' Guide to Bedaquiline |
treatmentactiongroup.org/content/tag-cofounder-gregg-gonsalv... | TAG Cofounder Gregg Gonsalves Receives 2018 MacArthur Fellowship |
treatmentactiongroup.org/content/activists-call-your-countri... | Activists: Call On Your Countries To Use BDQ-Based Regimens to Treat TB |
treatmentactiongroup.org/content/research-priorities-pediatr... | Research Priorities for Pediatric Tuberculosis |
treatmentactiongroup.org/content/funding-tb-research-recent-... | Funding for TB Research: Recent Momentum Must Inspire Bold Commitments |
treatmentactiongroup.org/riaa/2018 | Research in Action Awards 2018 |
treatmentactiongroup.org/content/exciting-changes-tag-team | Exciting Changes on the TAG Team |
treatmentactiongroup.org/sites/default/files/sahpra_8_23_18.... | Open Letter from Civil Society to the Regulatory Authority in South Africa |
treatmentactiongroup.org/content/webinar-implementing-inject... | Webinar: Implementing an Injectable-Free Regimen for Drug-Resistant Tuberculosis |
treatmentactiongroup.org/content/tb-cab-and-tag-welcome-who-... | The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of drug-resistant TB |
treatmentactiongroup.org/content/us-tb-and-access-medicines-... | U.S. TB and Access to Medicines Stakeholder Letter to U.S. Amb. Nikki Haley on HLM Declaration Negotiations |
treatmentactiongroup.org/content/comment-opposition-citizens... | Comment in Opposition to Citizenship Question on 2020 U.S. Census |
treatmentactiongroup.org/content/tag-applauds-new-york-gover... | TAG Applauds New York Governor for Committing to Statewide Hepatitis C Elimination Task Force, Action Puts NY at Forefront of He... |
treatmentactiongroup.org/content/migrants-inclusion-central-... | Migrants’ Inclusion Central to Achieving HIV and Hepatitis C Targets by 2030 |
treatmentactiongroup.org/tb/diagnostic-tools | An Activist’s Guide to Tuberculosis Diagnostic Tools |
treatmentactiongroup.org/tb/drug-guide-2016 | An Activist’s Guide to Tuberculosis Drugs |
treatmentactiongroup.org/content/activists-call-countries-an... | Activists Call on Countries and Donors to Immediately Scale Up Use of Life-Saving TB LAM Test |
treatmentactiongroup.org/content/strengthening-tb-research-n... | Strengthening TB Research in NIAID's Tuberculosis Strategic Plan |
treatmentactiongroup.org/hhs_drug_pricing_blueprint_rfi_hiv_... | White House and Congress Must Boldly Address Drug Pricing and Ensure Access to Critical HIV, HCV, and TB Medications |
treatmentactiongroup.org/sites/default/files/bedaquiline_pri... | Activists Call on Johnson & Johnson to Drop the Price of Bedaquiline |
treatmentactiongroup.org/content/tag-and-nyc-health-dept-res... | Mark Harrington of TAG and Dr. Demetre Daskalakis of NYC Health Dept. Respond to NY Times Opinion Piece About PrEP |
treatmentactiongroup.org/content/tb/tb-research-briefing-un-... | Videos from a TB Research Briefing for UN Missions, “The Vital Role of Research for TB Elimination" |
treatmentactiongroup.org/content/tag-welcomes-price-reductio... | TAG Welcomes Price Reductions For TB Medicines |
treatmentactiongroup.org/content/sign-letter-advocacy-end-pe... | Sign-On Letter: Advocacy to End Peace Corps HIV Dismissals |
treatmentactiongroup.org/content/webinar-ending-epidemic-bui... | Webinar: Ending the Epidemic - Building Effective Collaboration between Community Advocates and Health Departments |
treatmentactiongroup.org/affordable_medicines_now_conference | Affordable Medicines Now Conference: June 27–29, 2018 |
treatmentactiongroup.org/content/now-available-tools-help-su... | Tools to help support activists in engaging national policy makers on TB |
treatmentactiongroup.org/content/webinar-ending-epidemic-upd... | Webinar: Ending the Epidemic - Update on Implementing the New York State Blueprint |
treatmentactiongroup.org/content/spring-2018-tagline | TAGline Spring 2018 |
treatmentactiongroup.org/content/tag-statement-final-appropr... | TAG Statement on Final Appropriations for Fiscal Year 2018 |
treatmentactiongroup.org/content/ny-community-groups-call-ci... | New York Community Groups Call on City, State, Federal Actors to Increase Funding for Tuberculosis |
treatmentactiongroup.org/content/webinar-including-pregnant-... | Webinar: It's Time to Deliver - Including Pregnant and Lactating Women in Clinical Research, Pt 1 |
treatmentactiongroup.org/westbeth | here |
treatmentactiongroup.org/content/treatment-action-group-appl... | Read the full statement. |
treatmentactiongroup.org/content/is-shorter-better | Is Shorter Better? Understanding the Shorter Regimen for Treating Drug-Resistant Tuberculosis |
treatmentactiongroup.org/content/stop-false-hope | ACTION NEEDED: False Hope - Protect Your Right to Safe, Effective Medicines by Stopping the "Right to Try" Movement |
treatmentactiongroup.org/content/issue-brief-suboptimal-immu... | TAG Issue Brief: Suboptimal Immune Recovery on Antiretroviral Therapy |
treatmentactiongroup.org/content/civil-society-calls-novarti... | Civil society calls on Novartis to end 'bullying tactics' and respect countries' legal rights to make medicines more affordable |
treatmentactiongroup.org/content/ny-state-medicaid-director-... | NY State Medicaid Director Announces Potential Path for Volume Based Deal to Expand Hepatitis C Treatment at Lower Price |
treatmentactiongroup.org/content/statement-potus-fy19-budget... | Statement on POTUS FY19 Budget Release |
treatmentactiongroup.org/content/know-your-rights-tuberculos... | Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide |
treatmentactiongroup.org/content/letter-health-organizations... | Letter from Health Organizations: NAFTA Renegotiations Must Not Undermine Access to Affordable Medicines |
treatmentactiongroup.org/letter-gilead-pep-pap-policy-unethi... | Letter to Gilead Sciences Opposing Unethical Patient Assistance Program Policy for Truvada for Postexposure Prophylaxis |
treatmentactiongroup.org/discriminatory-conscious-and-religi... | Discriminatory Conscience and Religious Freedom Division Proposed Rule Threatens Our Most Vulnerable Communities |
treatmentactiongroup.org/content/webinar-good-cops-or-bad-co... | Webinar: Good COPs or Bad COPs? Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs) |
treatmentactiongroup.org/content/tag-mourns-loss-mathilde-kr... | TAG Mourns the Loss of Mathilde Krim, PhD |
treatmentactiongroup.org/content/securing-TB-free-future-thr... | Securing a Tuberculosis-Free Future through the Visionary Research of the CDC’s Tuberculosis Trials Consortium |
treatmentactiongroup.org/content/tag-joins-civil-society-cal... | TAG Joins Call to Oppose U.S. Secretary of Health and Human Services Appointment |
treatmentactiongroup.org/content/hasty-passage-tax-and-healt... | Hasty Passage of the Tax and Health Care Bill |
treatmentactiongroup.org/content/tag-statement-forbidden-wor... | TAG Statement on Forbidden Words in Budget Documents |
treatmentactiongroup.org/content/tag-statement-human-rights-... | TAG Statement to Human Rights Council on Human Rights Concerns in the UAE |
treatmentactiongroup.org/content/webinar-exploring-implicati... | Webinar: Exploring the Implications of the Delamanid Phase III and STREAM Trial Results |
treatmentactiongroup.org/content/2017-symposium-reframing-ri... | 2017 Symposium: Reframing Risk and Accountability for Action to ZERO TB |
treatmentactiongroup.org/content/hiv-cure-research-informati... | HIV Cure Research Information Sheet |
treatmentactiongroup.org/content/fall-2017-tagline | TAGline Fall 2017 |
treatmentactiongroup.org/content/sign-declaration-calling-dr... | Sign the Declaration Calling for Drug Decriminalization to Achieve Hepatitis Elimination |
treatmentactiongroup.org/content/changing-who-global-tb-prog... | Changing World Health Organization Global TB Program Leadership |
treatmentactiongroup.org/sites/default/files/2017annual.pdf | TAGupdate |
treatmentactiongroup.org/content/suboptimal-immune-recovery-... | Suboptimal Immune Recovery on Antiretroviral Therapy: Causes, Consequences, & the Search for Solutions |
treatmentactiongroup.org/content/remarks-erica-lessem-tb-res... | Remarks by Erica Lessem on TB research at the WHO Global Ministerial Conference on Ending TB |
treatmentactiongroup.org/tbrd2017 | The Ascent Begins: Tuberculosis Research Funding Trends, 2005–2016 |
treatmentactiongroup.org/content/end-epidemic-resources-sout... | End the Epidemic Resources: Southern States EtE Meeting Summary and FAQs |
treatmentactiongroup.org/content/forging-path-hcv-eliminatio... | Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics |
treatmentactiongroup.org/HHS_strategic_plan | US Health & Human Services (HHS) Strategic Plan FY 2018-2022: TAG Comments to the Assistant Secretary for Planning and Evaluatio... |
treatmentactiongroup.org/content/submission-office-united-na... | Submission to the Office of the United Nations High Commissioner for Human Rights to Report on Sustainable Development Goals and... |
/rss.xml | This site (RSS) |
Domain Name: TREATMENTACTIONGROUP.ORG
Registry Domain ID: D10291279-LROR
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://www.networksolutions.com
Updated Date: 2018-09-04T18:41:44Z
Creation Date: 1999-09-16T18:12:17Z
Registry Expiry Date: 2019-09-16T18:12:17Z
Registrar Registration Expiration Date:
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registrant Organization: TREATMENT ACTION GROUP
Registrant State/Province: NY
Registrant Country: US
Name Server: NS11.WORLDNIC.COM
Name Server: NS12.WORLDNIC.COM
URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/)
>>> Last update of WHOIS database: 2018-11-25T18:35:29Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
The Registrar of Record identified in this output may have an RDDS service that can be queried for additional information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used: http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html
User-agent: *
Crawl-delay: 10
# CSS, JS, Images
Allow: /misc/*.css$
Allow: /misc/*.css?
Allow: /misc/*.js$
Allow: /misc/*.js?
Allow: /misc/*.gif
Allow: /misc/*.jpg
Allow: /misc/*.jpeg
Allow: /misc/*.png
Allow: /modules/*.css$
Allow: /modules/*.css?
Allow: /modules/*.js$
Allow: /modules/*.js?
Allow: /modules/*.gif
Allow: /modules/*.jpg
Allow: /modules/*.jpeg
Allow: /modules/*.png
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /themes/*.css$
Allow: /themes/*.css?
Allow: /themes/*.js$
Allow: /themes/*.js?
Allow: /themes/*.gif
Allow: /themes/*.jpg
Allow: /themes/*.jpeg
Allow: /themes/*.png
# Directories
Disallow: /includes/
Disallow: /misc/
Disallow: /modules/
Disallow: /profiles/
Disallow: /scripts/
Disallow: /themes/
# Files
Disallow: /CHANGELOG.txt
Disallow: /cron.php
Disallow: /INSTALL.mysql.txt
Disallow: /INSTALL.pgsql.txt
Disallow: /INSTALL.sqlite.txt
Disallow: /install.php
Disallow: /INSTALL.txt
Disallow: /LICENSE.txt
Disallow: /MAINTAINERS.txt
Disallow: /update.php
Disallow: /UPGRADE.txt
Disallow: /xmlrpc.php
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips/
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register/
Disallow: /user/password/
Disallow: /user/login/
Disallow: /user/logout/
# Paths (no clean URLs)
Disallow: /?q=admin/
Disallow: /?q=comment/reply/
Disallow: /?q=filter/tips/
Disallow: /?q=node/add/
Disallow: /?q=search/
Disallow: /?q=user/password/
Disallow: /?q=user/register/
Disallow: /?q=user/login/
Disallow: /?q=user/logout/
США - 216.178.232.139
Data Return
Data Return
HTTP/1.1 200 OK
Date: Sat, 23 Nov 2019 22:18:14 GMT
Server: Apache
X-Powered-By: PHP/7.1.31
X-Drupal-Cache: HIT
Content-Language: en
X-Frame-Options: SAMEORIGIN
X-Generator: Drupal 7 (http://drupal.org)
Link: ; rel="canonical",; rel="shortlink"
Cache-Control: public, max-age=300
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Vary: Cookie,Accept-Encoding,User-Agent
Upgrade: h2,h2c
Connection: Upgrade
Etag: "1574479391-0"
Last-Modified: Sat, 23 Nov 2019 03:23:11 GMT
Transfer-Encoding: chunked
Content-Type: text/html; charset=utf-8
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"